2型糖尿病合并血管疾病的风险因素分析(2)
第1页 |
参见附件(2245KB,3页)。
[4]Buse JB,Ginsberg HN,Bakris GL,et al.Primary prevention of cardiovascular disease in people with diabetes mellitus:A scientific statement from the American Heart Association and the American Diabetes Association[J].Diabetes Care,2007,30:162-172.
[5]周厚广,董强,胡仁明.糖尿病性脑血管病的研究进展[J].中国脑血管病杂志,2009,6(1):49-53.
[6]Tan MH,MacLean DR.Epidemiology of diabetes mellitus in Canada[J].Clin Investigative Medicine,1995,18:240-246.
[7]Jude EB,Oyibo SO,Chalmers N,et al.Peripheral arterial disease in diabetic and nondiabetic patients[J].Diabetes Care,2001,24:1433-1437.
[8]Beckman JA,Creager MA,Libby P.Diabetes and atherosclerosis:Epidemiology,pathophysiology,and management[J].J Am Med Assoc,2002,287:2570-2581.
[9]Shih YH,Hung HL,Luo PG,et al.Clustering of unconventional cardiovascular risk factors among Taiwanese hemodialysis patients[J].Am J Nephrol,2009,30:222-231.
[10]Al-Maskari F,El-Sadig M,Norman JN.The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates[J].Cardiovascular Diabetology,2007,6:24.
[11]Morrish NJ,Stevens LK,Fuller JH,et al.Risk factors for macrovascular disease in diabetes mellitus:The London follow up to the WHO multinational study of vascular disease in diabetics[J].Diabetologia,1991,34(8):590-594.
[12]Abu-Lebdeh HS,Hodge DO,Nguyen TT.Predictors of macrovascular disease in patients with type 2 diabetes mellitus[J].Mayo Clinic Proceedings,2001,76(7):707-712.
[13]Janghorbani M,Amini M,Tavassoli A.Coronary heart disease in type Ⅱ diabetes mellitus in Isfahan,Iran:Prevalence and risk factors[J].Acta Cardiologica,2006,61(1):13-20.
作者简介:郭琳(1971—),女,主治医师,硕士研究生,现工作于山西省心血管疾病医院(邮编:030024);何军花,工作于山西医科大学第二医院。
(收稿日期:2011-01-16)
(本文编辑王雅洁)
您现在查看是摘要介绍页,详见PDF附件(2245KB,3页)。